Universal access to sexual and reproductive health services is essential to facilitate the empowerment of women and achievement of gender equality. Increasing access to modern methods of contraception can reduce the incidence of unplanned pregnancy and decrease maternal mortality. Long-acting reversible contraceptives (LARCs) offer high contraceptive efficacy as well as cost-efficacy, providing benefits for both women and healthcare systems. The levonorgestrel-releasing intrauterine system (LNG-IUS) first became available in 1990 with the introduction of Mirena (LNG-IUS 20), a highly effective contraceptive which can reduce menstrual blood loss and provide other therapeutic benefits. The impact of the LNG-IUS on society has been wide ranging, including decreasing the need for abortion, reducing the number of surgical sterilisation procedures performed, as well as reducing the number of hysterectomies carried out for issues such as heavy menstrual bleeding (HMB). In the context of the COVID-19 pandemic, Mirena can provide a treatment option for women with gynaecological issues such as HMB without organic pathology, minimising exposure to the hospital environment and reducing waiting times for surgical appointments. Looking to the future, research and development in the field of the LNG-IUS continues to expand our understanding of these contraceptives in clinical practice and offers the potential to further expand the choices available to women, allowing them to select the option that best meets their needs.

中文翻译：

---

不仅仅是避孕：释放左炔诺孕酮的宫内节育系统对公共卫生的影响超过 30 年

普遍获得性健康和生殖健康服务对于促进赋予妇女权力和实现性别平等至关重要。增加获得现代避孕方法的机会可以减少意外怀孕的发生率并降低孕产妇死亡率。长效可逆避孕药 (LARC) 具有很高的避孕效果和成本效益，为女性和医疗保健系统带来好处。释放左炔诺孕酮的宫内节育系统 (LNG-IUS) 于 1990 年随着曼月乐 (LNG-IUS 20) 的推出而首次面世，这是一种可以减少月经失血并提供其他治疗益处的高效避孕药。LNG-IUS 对社会的影响是广泛的，包括减少堕胎的需要，减少进行的外科绝育手术的次数，以及减少因月经过多 (HMB) 等问题而进行的子宫切除术的次数。在 COVID-19 大流行的背景下，曼月乐可为有妇科问题（如 HMB 等无器质性病变）的女性提供治疗选择，最大限度地减少与医院环境的接触并减少手术预约的等待时间。展望未来，LNG-IUS 领域的研究和开发将继续扩大我们在临床实践中对这些避孕方法的理解，并提供进一步扩大女性可用选择的潜力，使她们能够选择最适合自己的选择。需要。在 COVID-19 大流行的背景下，曼月乐可为有妇科问题（如 HMB 等无器质性病变）的女性提供治疗选择，最大限度地减少与医院环境的接触并减少手术预约的等待时间。展望未来，LNG-IUS 领域的研究和开发将继续扩大我们在临床实践中对这些避孕方法的理解，并提供进一步扩大女性可用选择的潜力，使她们能够选择最适合自己的选择。需要。在 COVID-19 大流行的背景下，曼月乐可为有妇科问题（如 HMB 等无器质性病变）的女性提供治疗选择，最大限度地减少与医院环境的接触并减少手术预约的等待时间。展望未来，LNG-IUS 领域的研究和开发将继续扩大我们在临床实践中对这些避孕方法的理解，并提供进一步扩大女性可用选择的潜力，使她们能够选择最适合自己的选择。需要。